Dendreon (formerly known as Activated Cell Therapy) is a biopharmaceutical company that engages in the development of immunotherapy. Its product PROVENGE (sipuleucel-T), a prescription medicine, is used to treat advanced prostate cancer.
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was Dendreon founded?
Dendreon was founded in 1992.
Who are Dendreon competitors?
Competitors of Dendreon include Gradalis, WindMIL Therapeutics and Ectin Research.
Receive alerts for 300+ data fields across thousands of companies